Supplemental Data from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409697.v1

2023-01-01

Abstract:Supplemental data includes supplement materials, methods and data

What problem does this paper attempt to address?

Supplemental Fig.S2. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409685

2023-01-01

Abstract:Supplemental Fig.S2. HEATR1 regulates cancer cell response to chemotherapy and cell growth
Supplemental Fig.S4. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409682

2023-01-01

Abstract:Supplemental Fig.S4. Akt inhibitor sensitizes pancreatic tumors with HEATR1 knockdown to gemcitabine.
Supplemental Fig.S.3 from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409694.v1

2023-01-01

Abstract:HEATR1 colocalized with Akt and regulates Akt phosphorylation independent of PDK1
Supplemental Fig.S.5. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409691.v1

2023-01-01

Abstract:Representative strong and weak staining of HEATR1 in pancreatic ductal adenocarcinoma.
Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Qianying Guo,Hao Wang,Jiahao Duan,Wenwu Luo,Rongrong Zhao,Yuting Shen,Bijun Wang,Siqi Tao,Yi Sun,Qian Ye,Xiaomin Bi,Hui Yuan,Qiang Wu,Peter E. Lobie,Tao Zhu,Sheng Tan,Xing Huang,Zhengsheng Wu

DOI: https://doi.org/10.1158/0008-5472.22432764.v1

2023-01-01

Abstract:Supplementary Data from An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer
HEATR1 Deficiency Promotes Chemoresistance Via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer

Yuan Fang,Xu Han,Jianang Li,Tiantao Kuang,Wenhui Lou

DOI: https://doi.org/10.1155/2020/3181596

IF: 4.501

2020-01-01

Journal of Oncology

Abstract:Objective To discover the correlated gene with HEATR1 in regulating chemoresistance of gemcitabine. Methods Gene chip analysis was performed to find out differential genes between HEATR1-KD and control groups. The top 20 genes were subjected to high-content screening, and functional assay was implemented. Gene expression profiling was carried out to find the downstream target. Immunohistochemistry and survival analysis were performed. Results ZNF185 fold change (4.5285) was the most significant between the HEATR1-KD and control groups. Knocking down ZNF185 could promote the chemosensitivity, apoptosis, and proliferative inhibition, with SMAD4 significantly upregulated. Patients with high HEATR1 and SMAD4 or low ZNF185 exhibited better survival. Conclusion HEATR1, ZNF185, and SMAD4 could affect the chemosensitivity of gemcitabine and may be the indicators of gemcitabine selection in the chemotherapy of pancreatic cancer.
Supplementary Data 1 from HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer

Tao Jiang,Qiqi Jin,Jiahao Wang,Fengying Wu,Jian Chen,Gongyan Chen,Yunchao Huang,Jianhua Chen,Ying Cheng,QiMing Wang,Yueyin Pan,Jianying Zhou,Jianhua Shi,Xingxiang Xu,LiZhu Lin,Wei Zhang,Yiping Zhang,Yunpeng Liu,Yong Fang,Jifeng Feng,Zhehai Wang,Sheng Hu,Jian Fang,Yongqian Shu,Jiuwei Cui,Yi Hu,Wenxiu Yao,Xingya Li,Xiaoyan Lin,Rui Wang,Yongsheng Wang,Wei Shi,Gaohua Feng,Jun Ni,Beibei Mao,Dandan Ren,Huaibo Sun,Henghui Zhang,Luonan Chen,Caicun Zhou,Shengxiang Ren

DOI: https://doi.org/10.1158/1078-0432.23791953.v1

2023-01-01

Abstract:Supplementary Materials
Supplementary Data from Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis

Li-Peng Hu,Xiao-Xin Zhang,Shu-Heng Jiang,Ling-Ye Tao,Qing Li,Li-Li Zhu,Ming-Wei Yang,Yan-Miao Huo,Yong-Sheng Jiang,Guang-Ang Tian,Xiao-Yan Cao,Yan-Li Zhang,Qin Yang,Xiao-Mei Yang,Ya-Hui Wang,Jun Li,Gary Guishan Xiao,Yong-Wei Sun,Zhi-Gang Zhang

DOI: https://doi.org/10.1158/1078-0432.22467476

2023-01-01

Abstract:Supplymentary data figure 1-8 and table 1-2
Supplementary Data from Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program

Ke Tang,Liyan Zhu,Jie Chen,Dianheng Wang,Liping Zeng,Chen Chen,Liang Tang,Li Zhou,Keke Wei,Yabo Zhou,Jiadi Lv,Yuying Liu,Huafeng Zhang,Jingwei Ma,Bo Huang

DOI: https://doi.org/10.1158/0008-5472.22430538.v1

2023-01-01

Abstract:Figure S1-7, Table S1
Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Yufei Wang,Man Zhao,Lina Zhao,Yu Geng,Guanghao Li,Lin Chen,Jingxuan Yu,Hongfeng Yuan,Huihui Zhang,Haolin Yun,Ying Yuan,Guowen Wang,Jinyan Feng,Liang Xu,Shuai Wang,Chunyu Hou,Guang Yang,Ningning Zhang,Wei Lu,Xiaodong Zhang

DOI: https://doi.org/10.1158/0008-5472.22433561.v1

2023-01-01

Abstract:Supplementary materials and methods, Supplementary figures, Supplementary figure legends, Supplementary tables
Supplementary Data from Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor Β–insensitive CD8+ T Cells

Longxin Wang,Weihong Wen,Jianlin Yuan,Brian Helfand,Yu Li,Changhong Shi,Feng Tian,Jia Zheng,Fuli Wang,Lin Chen,Lili Liang,Liqun Zhou,Chung Lee,Zhinan Chen,Yinglu Guo,He Wang,Qiang Zhang,Weijun Qin

DOI: https://doi.org/10.1158/1078-0432.22441593

2023-01-01

Abstract:Supplementary Data from Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor β–Insensitive CD8+ T Cells
Supplementary Data from Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (neoatp): Primary Analysis of a Phase II Study

Wenjin Yin,Yaohui Wang,Ziping Wu,Yumei Ye,Liheng Zhou,Shuguang Xu,Yanping Lin,Yueyao Du,Tingting Yan,Fan Yang,Jie Zhang,Qiang Liu,Jinsong Lu

DOI: https://doi.org/10.1158/1078-0432.ccr-22-0446

IF: 13.801

2022-01-01

Clinical Cancer Research

Abstract:Supplementary Data from Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study
Supplementary Data from High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma

Wen Sun,Shi-Chao Li,Li Xu,Wei Zhong,Zhen-Guang Wang,Chu-zhi Pan,Jing Li,Guang-Zhi Jin,Na Ta,Wei Dong,Dan Liu,Hui Liu,Hong-Yang Wang,Jin Ding

DOI: https://doi.org/10.1158/1078-0432.22472793

2023-01-01

Abstract:Supplementary Data
Supplementary Figure 4 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Carl G. Engelke,Leslie A. Parsels,Yushen Qian,Qiang Zhang,David Karnak,Jordan R. Robertson,Daria M. Tanska,Dongping Wei,Mary A. Davis,Joshua D. Parsels,Lili Zhao,Joel K. Greenson,Theodore S. Lawrence,Jonathan Maybaum,Meredith A. Morgan

DOI: https://doi.org/10.1158/1078-0432.22446756.v1

2023-01-01

Abstract:PDF file, 116K, Animal weight during treatment with MK8776, gemcitabine, and radiation.
Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Dongping Wei,Leslie A. Parsels,David Karnak,Mary A. Davis,Joshua D. Parsels,Amanda C. Marsh,Lili Zhao,Jonathan Maybaum,Theodore S. Lawrence,Yi Sun,Meredith A. Morgan

DOI: https://doi.org/10.1158/1078-0432.22450100

2023-01-01

Abstract:PDF file - 52K, LB100 causes an increase in pHistone H3 positive cells.
Supplementary Figure 1 from Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions

Won Young Tak,Shi-Ming Lin,Yijun Wang,Jiasheng Zheng,Aldo Vecchione,Soo Young Park,Min Hua Chen,Stephen Wong,Ruocai Xu,Cheng-Yuan Peng,Yi-You Chiou,Guan-Tarn Huang,Jianqiang Cai,Basri Johan Jeet Abdullah,June Sung Lee,Jae Young Lee,Jong-Young Choi,Julieta Gopez-Cervantes,Morris Sherman,Richard S. Finn,Masao Omata,Michael O'Neal,Lukas Makris,Nicholas Borys,Ronnie Poon,Riccardo Lencioni

DOI: https://doi.org/10.1158/1078-0432.22462277.v1

2023-01-01

Abstract:Supplementary Figure 1: Computational Modeling Study.
Supplementary Data from GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors

Yunzheng Li,Binghua Li,Yanchao Xu,Liyuan Qian,Tiancheng Xu,Gang Meng,Huan Li,Ye Wang,Laizhu Zhang,Xiang Jiang,Qi Liu,Yuanyuan Xie,Chunxiao Cheng,Beicheng Sun,Decai Yu

DOI: https://doi.org/10.1158/0008-5472.22432371.v1

2023-01-01

Abstract:Supplementary Data from GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors
Supplementary Tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Jialei Weng,Zheng Wang,Zhiqiu Hu,Wenxin Xu,Jia-Lei Sun,Fu Wang,Qiang Zhou,Shaoqing Liu,Min Xu,Minghao Xu,Dongmei Gao,Ying-Hao Shen,Yong Yi,Yi Shi,Qiongzhu Dong,Chenhao Zhou,Ning Ren

DOI: https://doi.org/10.1158/0008-5472.25964573.v1

2024-01-01

Abstract:The Supplementary Data consist of: Supplementary Tables S1-7
Fig S1-S8 from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer

Junchen Liu,Guo Chen,Zezhen Liu,Shaoyou Liu,Zhiduan Cai,Pan You,Yuepeng Ke,Li Lai,Yun Huang,Hongchang Gao,Liangcai Zhao,Helene Pelicano,Peng Huang,Wallace L. McKeehan,Chin-Lee Wu,Cong Wang,Weide Zhong,Fen Wang

DOI: https://doi.org/10.1158/0008-5472.22419839.v1

2023-01-01

Abstract:This file containing all the supplemental data supporting the statements indicated in the manuscripts.
Supplementary Data from Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

Li Liao,Yin-Ling Zhang,Ling Deng,Chao Chen,Xiao-Yan Ma,Lisa Andriani,Shao-Ying Yang,Shu-Yuan Hu,Fang-Lin Zhang,Zhi-Min Shao,Da-Qiang Li

DOI: https://doi.org/10.1158/0008-5472.22433349

2023-01-01

Abstract:Supplementary figures and tables

Supplemental Data from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S2. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S4. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S.3 from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplemental Fig.S.5. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

HEATR1 Deficiency Promotes Chemoresistance Via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer

Supplementary Data 1 from HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non–Small Cell Lung Cancer

Supplementary Data from Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis

Supplementary Data from Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program

Supplementary Data from HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression

Supplementary Data from Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor Β–insensitive CD8&lt;sup&gt;+&lt;/sup&gt; T Cells

Supplementary Data from Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (neoatp): Primary Analysis of a Phase II Study

Supplementary Data from High FLT3 Levels May Predict Sorafenib Benefit in Hepatocellular Carcinoma

Supplementary Figure 4 from Sensitization of Pancreatic Cancer to Chemoradiation by the Chk1 Inhibitor MK8776

Supplementary Figure 5 from Inhibition of Protein Phosphatase 2A Radiosensitizes Pancreatic Cancers by Modulating CDC25C/CDK1 and Homologous Recombination Repair

Supplementary Figure 1 from Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions

Supplementary Data from GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors

Supplementary Tables from Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy

Fig S1-S8 from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer

Supplementary Data from Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

Supplementary Data from Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor Β–insensitive CD8<sup>+</sup> T Cells